Pharmaceutical preparations company · DE · FY ends Dec · Revenue $0.00 · -$180M FCF
ROIC dropped from -42.89% to -46.30%, capital efficiency is deteriorating. Negative free cash flow of -$190M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$209M
▲ +13.8% YoY
Op. Margin
—
ROIC
-53.17%
▼ -3.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$180M
▲ +11.7% YoY
Op. Cash Flow (TTM)
-$180M
▲ +9.4% YoY
Net Debt
-$120M
Net Cash Position
Cash & Equiv.
$144M
Continue Research